The small scale bioreactors market consist of fermentation equipment that can be used for cell culture, fermentation, microbial cultivation and bioprocess monitoring on a small scale in research and development laboratories. Small scale bioreactors ranging from 100ml to 2L capacities are made from stainless steel and are ideal for microbial fermentation, cell culture, industrial processes, process optimization and quality control. These scale-appropriate bioreactors are cost effective, accessible and give reliable data at early stages of biopharmaceutical development.
The Global Small Scale Bioreactors Market Demand is estimated to be valued at US$ 1738.21 Mn in 2024 and is expected to exhibit a CAGR of 3.8% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the small scale bioreactors are LabCorp, Quest Diagnostics, Abbott Laboratories, Bio-Rad Laboratories, Inc., bioMérieux SA, DiaSorin S.p.A, T2 Biosystems, Inc., F. Hoffmann-La Roche AG, Meridian Bioscience, Inc., Quidel Corporation, and Thermo Fisher Scientific Inc. The growing demand for biotherapeutics and rising prevalence of chronic and infectious diseases is propelling the small scale bioreactors market. Technological advancements in bioprocessing techniques such as automated data logging, pH and dissolved oxygen probes, spargers and harvest ports allow for consistent and reproducible cell culture and fermentation at small scales.
Market trends
There is an increase in outsourcing of biopharmaceutical manufacturing which is driving the demand for small scale bioreactors in contract research and manufacturing organizations. Adoption of single use technologies and systems is a key trend witnessed in the small scale bioreactors market owing to benefits such as reduced cleaning validations.
Market Opportunities
Growth opportunities in emerging markets of Asia Pacific and Latin America due to increasing research interest and funding for biotechnology. Rising government support for development of biosimilars and biologics will augment investments in small scale bioreactors market.
Impact of COVID-19 on Small Scale Bioreactors Market Growth
The COVID-19 pandemic has significantly impacted the growth of the small scale bioreactors market. During the initial months, production and supply chain disruptions negatively affected the market. Lockdowns and restrictions limited the operations of biopharma companies and R&D activities in laboratories. This led to delays in projects and impacted new product development initiatives using small scale bioreactors.
However, with time the market has recovered owing to increasing vaccine development efforts and therapies for COVID-19 treatment. Major pharmaceutical firms are collaborating with biotech startups to develop vaccines and monoclonal antibodies at a rapid pace. This has fueled the demand for the small scale bioreactors used in early stage processes like cell line development, process development and clinical trial material production. Several new facilities have also come up to increase biomanufacturing capacities. In the coming years, continuous investments in developing long term preparedness against such pandemics are expected to sustain the growth momentum of this market.
Geographical Regions with Concentrated Small Scale Bioreactors Market Value
North America dominates the small scale bioreactors market in terms of value. This can be attributed to presence of large biopharma industry and tremendous research expenditures in the region. Countries like US and Canada have emerged as global leaders for biologics production. In addition, supportive regulatory environment and heavy funding for innovation has accelerated therapeutic development activities. Asia Pacific is considered as the fastest growing regional market. Rising biosimilars demand and increasing outsourcing of clinical and commercial manufacturing to China and India is fueling equipment procurement. Government initiatives to strengthen healthcare infrastructure and biotech industry offer significant opportunities.
Growing Demand in Asia-Pacific Region for Small Scale Bioreactors Market
The Asia Pacific region is emerging as the fastest growing market for small scale bioreactors. Rapid economic development, growing middle class population, increased healthcare access and rising lifestyle diseases have augmented the demand for biologics in several countries like China, India, South Korea and Japan. At the same time, governments are implementing favorable regulations and investing heavily to develop their domestic biomanufacturing capabilities. This is attracting large global pharmaceutical companies to set up Asia-centric R&D and manufacturing sites to reduce production costs and address the local market needs. These factors coupled with outsourcing trends have amplified bioreactor procurement in this region. Going forward, strategic partnerships, technology transfers and talent development will further propel small scale bioreactors market growth across Asia Pacific.
Get more insights on this topic: Small Scale Bioreactors Market
